Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
Du M, Gu J, Liu C, Liu N, Yu Z, Zhou C, Heng W, Cao Z, Wei F, Zhu K, Wang Y, Zhang W, Xue X, Zhang Y, Qian J.
Du M, et al. Among authors: heng w.
J Exp Clin Cancer Res. 2022 Apr 23;41(1):154. doi: 10.1186/s13046-022-02344-y.
J Exp Clin Cancer Res. 2022.
PMID: 35459258
Free PMC article.